|
NDUFS7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.349600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.384400E-01 |
| Normal-vs-Stage2 |
1.496000E-03 |
| Normal-vs-Stage3 |
6.620600E-01 |
| Normal-vs-Stage4 |
6.927200E-01 |
| Stage1-vs-Stage2 |
3.633800E-04 |
| Stage1-vs-Stage3 |
9.737600E-01 |
| Stage1-vs-Stage4 |
2.827400E-01 |
| Stage2-vs-Stage3 |
2.635200E-03 |
| Stage2-vs-Stage4 |
3.648600E-04 |
| Stage3-vs-Stage4 |
3.612200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.272800E-01 |
| Normal-vs-AfricanAmerican |
9.609000E-01 |
| Normal-vs-Asian |
3.332800E-01 |
| Caucasian-vs-AfricanAmerican |
9.883800E-01 |
| Caucasian-vs-Asian |
3.073800E-01 |
| AfricanAmerican-vs-Asian |
4.702200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.355600E-01 |
| Normal-vs-Female |
5.353000E-01 |
| Male-vs-Female |
3.999200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.113000E-01 |
| Normal-vs-Age(41-60Yrs) |
6.662000E-01 |
| Normal-vs-Age(61-80Yrs) |
5.643800E-02 |
| Normal-vs-Age(81-100Yrs) |
9.702600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.078600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.807900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.178600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.652300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.161600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.824200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.421400E-01 |
| Classical-VS-Follicular |
2.24242846513789E-12 |
| Classical-VS-Other |
5.048600E-01 |
| Classical-VS-Normal |
2.878000E-01 |
| Tall-VS-Follicular |
5.48749999884635E-08 |
| Tall-VS-Other |
3.627600E-01 |
| Tall-VS-Normal |
2.714600E-01 |
| Follicular-VS-Other |
6.694100E-02 |
| Follicular-VS-Normal |
1.68910999999161E-05 |
| Other-VS-Normal |
8.431200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.744300E-03 |
| Normal-vs-N1 |
9.785000E-01 |
| N0-vs-N1 |
1.959590E-02 |
|
|
